Dystonia is characterized by sustained muscle

Size: px
Start display at page:

Download "Dystonia is characterized by sustained muscle"

Transcription

1 This article has been updated from its originally published version to replace Figure 2 and update the legend. See the corresponding erratum notice, DOI: / / JNS13844a, for full details. J Neurosurg 119: , 2013 AANS, 2013 A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia Clinical article Lisbeth Schjerling, M.D., 1,2 Lena E. Hjermind, M.D., Ph.D., 3,4 Bo Jespersen, M.D., 1 Flemming F. Madsen, M.D., D.Sc., 1 Jannick Brennum, M.D., D.Sc., 1 Steen R. Jensen, R.N., 5 Annemette Løkkegaard, M.D., Ph.D., 5 and Merete Karlsborg, M.D. 5 1 Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital; 2 Department of Emergency, Hilleroed Hospital, Copenhagen University Hospital; 3 Section of Neurogenetics, Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital; 5 Department of Neurology, Bispebjerg, Copenhagen University Hospital, Copenhagen, Denmark; and 4 Department of Cellular and Molecular Medicine, Section of Neurogenetics, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark Object. The authors aim was to compare the subthalamic nucleus (STN) with the globus pallidus internus (GPi) as a stimulation target for deep brain stimulation (DBS) for medically refractory dystonia. Methods. In a prospective double-blind crossover study, electrodes were bilaterally implanted in the STN and GPi of 12 patients with focal, multifocal, or generalized dystonia. Each patient was randomly selected to undergo initial bilateral stimulation of either the STN or the GPi for 6 months, followed by bilateral stimulation of the other nucleus for another 6 months. Preoperative and postoperative ratings were assessed by using the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and video recordings. Quality of life was evaluated by using questionnaires (36-item Short Form Health Survey). Supplemental Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores were assessed for patients with focal dystonia (torticollis) by examining the video recordings. Results. On average for all patients, DBS improved the BFMDRS movement scores (p < 0.05) and quality of life physical scores (p < 0.01). After stimulation of the STN, the mean 6-month improvement in BFMDRS movement score was 13.8 points; after stimulation of the GPi, this improvement was 9.1 points (p = 0.08). Quality of life did not differ significantly regardless of which nucleus was stimulated. All 12 patients accepted 6 months of stimulation of the STN, but only 7 accepted 6 months of stimulation of the GPi. Among those who rejected stimulation of the GPi, 3 accepted concomitant stimulation of both the STN and GPi for 6 months, resulting in improved quality of life physical and mental scores and BFMDRS movement scores. Among the 4 patients who were rated according to TWSTRS, after 6 months of stimulation of both the STN and GPi, TWSTRS scores improved by 4.7% after stimulation of the GPi and 50.8% after stimulation of the STN (p = 0.08). Conclusions. The STN seems to be a well-accepted, safe, and promising stimulation target in the treatment of dystonia, but further studies are necessary before the optimal target can be concluded. Simultaneous stimulation of the STN and GPi should be further investigated. Clinical trial registration no.: KF /01 (Committees on Biomedical Research Ethics of the Capital Region of Denmark). ( Key Words subthalamic pallidal DBS deep brain stimulation randomized dystonia quality of life functional neurosurgery Dystonia is characterized by sustained muscle contractions that cause twisting and repetitive movements or abnormal postures. It is classified according to age at onset, localization of symptoms, and supposed etiology. 9 Although assumed to be a dysfunction in the processing of sensorimotor signals, the exact pathophysiology of dystonia is still unclear; it might differ for Abbreviations used in this paper: BFMDRS = Burke-Fahn-Marsden Dystonia Rating Scale; DBS = deep brain stimulation; GPi = globus pallidus internus; PD = Parkinson s disease; SF-36 = 36-item Short Form Health Survey; STN = subthalamic nucleus; TWSTRS = Toronto Western Spasmodic Torticollis Rating Scale. primary and secondary dystonia. 5 Medical treatment can be troublesome, leading to unacceptable side effects or insufficient or unsustained symptom relief. Well known as a treatment for Parkinson s disease (PD), deep brain stimulation (DBS) has become an effective alternative or supplement to medical treatment of dystonia. 6,16 20,23,24,28,30,31 It is based on implantation of electrodes into specific target areas in the brain, which deliver low-voltage stimulation with high frequency. Deep brain stimulation is assumed to disrupt pathological signals and perhaps also influence the release of neurotransmitters. 13 At most centers, the preferred DBS target for pa- 1537

2 L. Schjerling et al. tients with dystonia has been the globus pallidus internus (GPi). 16,19,20,30,31 However, for patients with PD, stimulation of the STN has also been effective for controlling dystonic symptoms. 21 We expected that stimulation of the STN might also be effective for controlling dystonic symptoms in patients without PD, perhaps even more effective than stimulation of the GPi. This expectation is supported by theoretical assumptions describing the functional organization of the basal-ganglia-thalamocortical circuits, 1,13 including the proposed direct, indirect, and hyperdirect pathways. 1,13,22,35 The STN has been suggested to be a central nucleus in the indirect and hyperdirect pathways and to have a substantial effect on the control of basal ganglia output. Recent studies among 1 12 patients have shown that the STN can be used as a target in the treatment of dystonia; results have been promising, supporting the assumption that the STN might be a better target than the GPi. 6,18,21,24,28 To further investigate this assumption, we conducted this double-blind randomized study comparing the STN and the GPi as DBS targets in the treatment of dystonia; we used alternating stimulation through electrodes placed in the STN and the GPi. Methods Patients During the period from 2002 to 2009, patients consecutively admitted to the Department of Neurology, Bispebjerg Hospital, Copenhagen, were included in the study. The inclusion criteria were medically intractable dystonia and age years. The exclusion criteria were inability to speak and understand Danish fluently, short life expectancy, alcohol or drug abuse, psychiatric disease, followup impossibility, or presence of structural brain lesions. This clinical trial was approved in 2001 and monitored by the Committees on Biomedical Research Ethics of the Capital Region of Denmark (no. KF /01). Molecular genetic tests were performed for the most frequent mutations in the dystonia genes: DYT1 (TOR1A), DYT5a (GCH1), and DYT11 (SGCE). Preoperative brain MRI was performed for surgical planning and exclusion of structural brain lesions. The patients were evaluated by a neuropsychologist to detect cognitive dysfunctions and, if clinically relevant, by a psychiatrist to exclude psychiatric diseases. Surgical Procedure Stereotactic framed-based CT scans of the brain were fused with preoperative MR images using Stereoplan (Radionics) or I-plan (Brainlab). The target point was marked on T2-weighted MR images by visual comparison with the Schaltenbrand-Wahren stereotactic atlas, and an entry point was selected on the top of the middle frontal gyrus, avoiding sulci and lateral ventricles. Target points were placed central in the STN and posteroventral in the GPi. Stereotactic placement of electrodes was performed, and the optimal placement was confirmed through microrecording. All operations were performed by the same 2 experienced neurosurgeons at the Department of Neurosurgery, Rigshospitalet, Copenhagen. Postoperative MRI or CT was performed to confirm the correct position of the electrodes. Patients were transferred to the Department of Neurology at Bispebjerg Hospital for adjustment of stimulation parameters. Postoperative Assessment The day after surgery, the patients were randomly selected by the research nurse, using a statistically validated randomization table, to receive DBS of the STN or the GPi for the first 6 months. The nuclei were activated bilaterally. A double monopolar setting was chosen. The pulse width and frequency were held constant at 60 msec and 130 Hz, respectively; the amplitude was increased in increments of 0.1 V to 0.5 V per day, with a goal of reaching 2.5 V in the nucleus within the first 2 weeks. The contacts, amplitude, and pulse width were adjusted during the next 5.5 months until the optimal stimulation parameters were established, that is, by adjusting the settings after each month of stable settings. After 6 months, the site of stimulation was changed to the alternate target and the procedure was repeated. If a satisfactory effect was not achieved when either the STN or the GPi was stimulated, concomitant stimulation in both the STN and the GPi for 6 months was offered. All adjustments were performed by the same experienced nurse throughout the study. Clinical Evaluation For each period of stimulation, the severity of dystonia was rated preoperatively and after 1 week, 3 months, and 6 months. All ratings were performed by 2 experienced neurologists using the Burke-Fahn-Marsden Dystonia Rating Scales (BFMDRSs) for movement (BFMDRS movement) and disability (BFMDRS disability). 9 The ratings were documented by video recordings. Video 1 shows the evaluation of Patient 1. Video 1. Clip demonstrating part of the clinical evaluation of Patient 1. Evaluation is shown before the procedure, during DBS in the STN and then during DBS in the STN and the GPi simultaneously. Copyright Lisbeth Schjerling. Published with per mission. Click here to view with Media Player. Click here to view with Quicktime. Raters and patients were blinded as to which site was stimulated. Quality of life was evaluated using the 36- item Short Form General Health Survey (SF-36), 34 which was completed by the patients before the procedure and at 3 and 6 months after the procedure, for each period of stimulation. The questions were related to either physical health (physical function, physical role, body pain, and general physical health [quality of life physical score]) or to mental health (vitality, social function, emotion, and general mental health [quality of life mental score]). Post hoc analyses of the videos of patients with torticollis were performed according to the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). 7 Ethics The patients gave written consent to participate in the study, and the study protocol was approved by the Committee of Science and Ethics, Copenhagen. Separate written consent was obtained from the patient shown in Video 1 (Patient 1). 1538

3 Subthalamic or pallidal DBS for dystonia Statistical Analysis Burke-Fahn-Marsden Dystonia Rating Scale data were analyzed by using hypothesis testing based on an intention-to-treat statistical analysis with repeated measures and correlation for time. The Wilcoxon signed-rank test was used to compare TWSTRS data. A descriptive statistical method was used in figures and for comparing means. Standard errors of means were calculated when appropriate. A p value 0.05 was considered significant; a trend was considered for p values between 0.05 and 0.10; and a p value > 0.10 was considered not significant. Results Patients Of the 13 patients who agreed to participate in the study, 6 had generalized dystonia, 1 had multifocal dystonia, and 6 had focal dystonia (all torticollis). The mean patient age at disease onset was 35.3 years (range years), and the mean age at time of surgery was 51 years (range years). The mean duration of disease was 16.2 years (range 3 30 years). Eleven patients were negative for the DYT1, DYT5, and DYT11 mutations; the other 2 (Patients 11 and 12) did not agree to undergo molecular genetic testing. For 11 patients, the dystonia was diagnosed as primary by medical history, biochemical analyses, and neuroimaging. For 2 patients (Patients 2 and 8), the dystonia was believed to be caused by previous medication, either neuroleptics (clozapine or haloperidol) or metoclopramide; each of these 2 patients experienced focal dystonia. Preoperative data are shown in Table 1. Preoperatively, 11 patients received botulinum toxin injections, 2 of whom had discontinued botulinum toxin because of lack of effectiveness. Postoperatively, only 2 patients continued treatment with botulinum toxin. In addition to adjustment of the botulinum treatment, other changes in the medical treatment throughout the study period were insignificant. Eight patients (Patients 2, 3, 5, 6, and 8 11) completed the stimulation protocol as planned and received stimulation of each target for 6 months. However, 1 patient (Patient 10) could not complete the final ratings because of concomitant disease unrelated to the study (a fractured leg). Some patients did not follow the protocol. Patient 13 was excluded from the study early because of an infection that necessitated removal of the electrodes. For Patient 7, signs of depression developed after 3 months of stimulation of the first target (GPi), and dystonic symptoms showed no improvement. Further stimulation of this target was therefore not acceptable, and at the 3-month ratings it was decided to change to the second target (STN), which was subsequently stimulated for 6 months as planned. The patient and raters were still blinded; for that reason, the patient was not excluded despite the interrupted protocol. Patients 1, 4, and 12 did not accept the change of stimulation target from the first (STN) to the second (GPi) because of worsening dystonia. It was consequently decided to stimulate both targets simultaneously (unblinded) for 6 months, although this procedure was not originally described in the protocol. Placement of Electrodes Single-channel microrecording was applied. Alternative trajectories were tested, but for only 1 patient did the alternative trajectory produce more optimal recordings, and, consequently, placement of the electrode was changed. The localization of the electrodes was investigated with postoperative MRI and/or CT (Fig. 1); 1 patient (Patient 12) refused to undergo postoperative imaging. For optimal localization, postoperative CT scans were merged with preoperative T2-weighted MR images. The position of the electrodes was plotted on the Schaltenbrand atlas by visual comparison with the nuclei TABLE 1: Clinical data and preoperative ratings* BFMDRS Score QOL Score Patient No. Age at Onset (yrs), Sex Duration (yrs) Phenotype Etiology Mov Dis Phys Ment Primary DBS Site 1 39, M 17 generalized primary STN 2 52, F 7 focal secondary GPi 3 34, F 4 generalized primary STN 4 16, F 22 multifocal primary STN 5 45, F 21 focal primary GPi 6 25, M 26 generalized primary STN 7 40, F 20 focal primary GPi 8 57, F 3 focal secondary Gpi 9 12, F 21 generalized primary GPi 10 52, F 16 focal primary STN 11 47, F 9 focal primary STN 12 28, F 15 focal primary STN 13 12, M 30 generalized primary STN * Dis = disability; Ment = mental; Mov = movement; Phys = physical; QOL = quality of life. Patient 13 was excluded from the study (because of electrode removal). 1539

4 L. Schjerling et al. Fig. 1. Postoperative MR image demonstrating the position of the implanted electrodes in the axial plane. as seen on T2-weighted MR images (Fig. 2). Most electrodes were positioned near the intended location (central in the STN and posteroventral in the GPi), but for 3 patients (Patients 4, 5, and 7), the electrodes in the GPi were placed more anteroventrally than posteroventrally. These 3 patients had either multifocal or generalized dystonia. BFMDRS Movement and Disability Scores Intention-to-treat analysis with repeated measures of all included patients showed a significant effect of DBS on BFMDRS movement scores (p < 0.05). Improvements were seen after the 1st week of STN or GPi stimulation (Fig. 3). The 6-month BFMDRS movement scores for the first period were improved by 10.8 ± 4.4 points compared with an improvement of 13.8 ± 6.2 points for the second period. When ratings from the first and second periods were combined, the mean 6-month improvement of BFM- DRS movement scores was 13.8 ± 4.2 points (44%) after STN stimulation compared with 9.1 ± 6.7 points (8%) after GPi stimulation. Testing the hypothesis that for patients with dystonia the STN could be a better target than the GPi, intention-to-treat analysis was correlated for time and data as referred to the baseline to compensate for the possible difference between nuclei being stimulated in the first or second period. Intention-to-treat analysis then showed a trend for better improvement during the STNstimulated period compared with the GPi-stimulated period (p = 0.08). It is notable that in following the intention-to-treat concept, the scores from the 3 patients who received stimulation to both targets instead of to the second target alone (GPi) in the second period were included in the statistical analysis as GPi results. This inclusion of these scores might explain why we found only a trend for the STN being superior despite finding an apparently marked difference in mean BFMDRS movement scores in the descriptive analysis. With respect to BFMDRS disability score, intentionto-treat analysis with repeated measurements showed no significant effect of time or nucleus stimulated. The mean 6-month improvement in BFMDRS disability score was 1.8 ± 0.6 for STN stimulation and 1.3 ± 1.2 for GPi stimulation. The mean improvements in BFMDRS movement scores are shown in Fig. 3. For the 6 patients with multifocal or generalized dystonia, BFMDRS movement scores improved by 23.8 ± 4.8 points (46%) after 6 months of either STN or GPi stimulation. For the 6 patients with torticollis (primary or secondary), BFMDRS movement scores improved by 1.5 ± 1.8 points (17%). For the 2 patients with secondary dystonia (Patients 2 and 8), scores showed negative or very little effects of GPi stimulation. For 2 patients who initially received GPi stimulation (Patients 2 and 5), the averaged BFMDRS movement and BFMDRS disability scores suggested worsening at 6 months (BFMDRS movement scores increased from 12 to 24.5 and from 7.5 to 12, respectively). The electrodes were located posteroventrally in the GPi, as intended, in Patient 2 but were located quite anteriorly in Patient 5. Changing the target to the STN resulted in improvement for both patients. For 2 other patients (Patients 4 and 7), electrodes were placed anteriorly and centrally in the GPi according to postoperative MR and CT images. Patient 4 initially received STN stimulation, and the BFMDRS movement score improved from 43 to 19 after 6 months. When the target was changed to the GPi, 1-week ratings still showed marked improvement (BFMDRS movement score 24), despite the frontally located electrodes. However, this patient did not accept the worsening in symptoms when the stimulated target changed from the STN to the GPi and refused further stimulation of the GPi. Instead, concomitant stimulation of the STN and the GPi was performed. For Patient 7, for whom electrodes were suboptimally positioned, the BFMDRS movement score did not change after GPi stimulation but did improve from 8 (preoperative rating) to 2 (6-month rating) with STN stimulation. For 3 patients (Patients 1, 4, and 12) who did not accept change of the target, simultaneous stimulation of the STN and the GPi was performed, as illustrated in Fig. 3C. For these patients, BFMDRS movement scores improved more when receiving stimulation to both targets than when receiving stimulation to the STN alone. For the BFMDRS movement scores, when both targets were stimulated, mean score improvement from preoperative to 6 months was 38.0 (77%); when only the STN was stimulated, mean improvement was 23.5 (48%). For the BFMDRS disability score, when both targets were stimulated, mean improvement was 4.0 (30%); when only the STN was stimulated, mean improvement was 2.0 (14%). TWSTRS Scores The 6 patients with focal dystonia were also rated according to TWSTRS (Table 2). Because TWSTRS scores were estimated retrospectively from video recordings, it was not possible to determine subscore C (the effect of sensory trick). These subscores are therefore not included in the total TWSTRS scores. Only 4 of the 6 patients with focal dystonia complet- 1540

5 Subthalamic or pallidal DBS for dystonia Fig. 2. Eleven patients had postoperative documentation of the electrode placement: 4 by MRI, 3 by CT, and 4 by both. The center of each electrode was marked on axial slides of postoperative CT or FLAIR MR images, which were fused to preoperative T2-weighted MR images to ensure that anatomical structures were not influenced by artifacts. The positions are marked on a standard anatomical atlas. AC = anterior commissure; Fx = fornix; GPe = globus pallidus externus; GPi = globus pallidus internus; Int. Cap. = internal capsule; MMT = mamillothalamic tract; Ruber = nucleus ruber (red nucleus); STN = subthalamic nucleus; III = third ventricle. A: GPi. B: STN. ed 6 months of stimulation of both the STN and the GPi, respectively. Stimulation effects differed; the median improvement in TWSTRS score with GPi stimulation was 1 point, whereas that with STN stimulation was 13 points. For those 4 patients, the mean improvement in TWSTRS score with GPi stimulation was 4.8%, and that with STN stimulation was 50.9%. The difference between stimulation of the STN and the GPi did not, however, reach statistical significance (p = 0.08). Quality of Life Scores Intention-to-treat statistical analysis of repeated measurements in all included patients showed that DBS had a significant effect on the quality of life physical score (p < 0.01) but not on the quality of life mental score. After 6 months of DBS, the mean increase in the quality of life physical score was 17.9 ± 4.5 points (58%), and the mean increase in the quality of life mental score was 13.1 ± 4.7 points (37%). A comparison of the effects of stimulation of the STN and the GPi showed that after 6 months, the mean improvements in quality of life physical scores were 22.5 ± 6.1 points (68%) and 10.1 ± 5.5 points (41%), respectively. The mean improvement in quality of life mental scores Fig. 3. Ratings in BFMDRS (BFM) movement score. A: The 5 patients who initially received GPi stimulation followed by STN stimulation. B: The 4 patients who initially received STN stimulation followed by GPi stimulation. C: The 3 patients who initially received STN stimulation but did not accept stimulation of the GPi and instead received 6 months of simultaneous STN and GPi stimulation. 1w = 1 week; 3m = 3 months; 6m = 6 months. 1541

6 L. Schjerling et al. TABLE 2: Summary of TWSTRS ratings for patients with torticollis* Time Patient No Significance preop score wk score STN 6 ND GPi ND 12 NS 3-mo score STN ND 8 19 ND GPi NS 6-mo score STN GPi ND 23 ND 26 NS * ND = ratings not done; NS = not significant. Subscore C could not be determined from video recordings and therefore is not included in the TWSTRS scores. p = was 20.1 ± 6.3 points (55%) with STN stimulation but 1.1 ± 4.4 points (4%) with GPi stimulation (Fig. 4). However, using intention-to-treat statistical analysis for testing the study hypothesis, we found that quality of life-physical (p = 0.14) or quality of life-mental scores did not differ significantly with stimulation of the STN or the GPi (p = 0.13). For the 3 patients who received simultaneous stimulation of the STN and the GPi, the mean quality of life physical scores improved by 43.2 points (126%) after 6 months of stimulation of both targets and by 39.9 points (111%) after 6 months of STN stimulation only. For these same 3 patients, the quality of life mental score improved 37.4 points (115%) after 6 months of simultaneous STN and GPi stimulation compared with 39.3 points (123%) after 6 months of STN-only stimulation. Stimulation Parameters All patients received stimulation at 130 Hz. In the respective 6-month study periods, maximum amplitudes in individual patients were 4.0 V for the GPi and 3.6 V for the STN. A maximum pulse width of 240 msec was attempted for the GPi and 90 msec for the STN. A pulse width below 60 msec was not attempted for either target. The mean voltage settings were 2.8 ± 0.2 V for the GPi and 2.6 ± 0.12 V for the STN. The optimal pulse width was ± 18.0 msec for the GPi and 60.0 msec for the STN. Postoperative Complications In 2 patients (Patients 6 and 13), infection developed and resulted in unilateral removal of both electrodes and stimulator. For Patient 6, the stimulator was later reimplanted and the protocol was resumed without further complications. Patient 13 was excluded because of the permanent removal of the electrodes. Two months after surgery, Patient 11 experienced lipothymia and was evaluated with blood tests and electrocardiography; results were within reference range. Epilepsy was not suspected. The patient continued stimulation as planned with no further complications. Adverse Events For 3 patients who received GPi stimulation (Patients 5, 7, and 11), signs of depression developed despite stimulator setting adjustments. Patient 11 responded well to citalopram during continued GPi stimulation, and the other 2 patients improved after the target was changed to the STN. Two patients complained of reduced neck mobility, thought to be a possible consequence of the electrical wires. Reoperation was not necessary. Hyperkinesia was seen, especially with stimulation of the STN, but it was generally mild and responsive to adjustment. Microlesion effects were suspected in 3 patients with initial hyperkinesia and spontaneous improvement within weeks of the operation. Sustained hyperkinesia despite optimal adjustments was seen in 3 patients (2 with STN stimulation and 1 with GPi stimulation). Other adverse effects were temporary and insignificant, such as mild hypomania, dysphagia, and nausea, and resolved without treatment when optimal stimulation settings were accomplished. Discussion To our knowledge, ours is the first randomized double-blind study to compare DBS of the GPi with DBS of the STN as target nuclei in patients with dystonia. Thirteen patients agreed to participate; 1 was excluded. Both STN and the GPi stimulation exhibited a significant clinical effect. We found no statistically significant difference in BFMDRS scores when comparing the targets, but the results suggest that stimulation of the STN produced a greater improvement in BFMDRS movement scores than did stimulation of the GPi. Stimulation of the STN resulted in better compliance. Six months of STN stimulation was completed by 12 pa- 1542

7 Subthalamic or pallidal DBS for dystonia Fig. 4. Quality of life (QOL) scores were calculated for all patients preoperatively and after 6 months of stimulation of the GPi, the STN, or both (GPi+STN). Scores are presented as mean ± SEM (error bars). tients, but 6 months of GPi stimulation was completed by only 8 patients (including the patient who was not rated because of concomitant disease). Moreover, we found that STN stimulation resulted in no more adverse effects than did GPi stimulation. We chose to implant electrodes in both the STN and the GPi and randomly assign the patients to initial stimulation of the STN or the GPi, followed by stimulation of the other nucleus. In this way the patients were their own controls and statistical variations were minimized. Because of the low number of patients in this study, an alternative design would be more sensitive to the preoperative severity of disease and the response to DBS. In our study, 3 patients who left the blinded full program after the first period of STN stimulation received simultaneous stimulation of the STN and the GPi. To our knowledge, double stimulation for pure dystonia has not been previously described. It has, however, been reported for 3 patients with dystonia-parkinsonism; the effect was reported to be either equal or additional to that of STN or GPi stimulation alone. 4,36 Our study showed an additional effect for 2 of the 3 patients stimulated at both the STN and the GPi, suggesting that simultaneous stimulation of the STN and the GPi might produce an additional effect in patients with dystonia. Further studies are warranted to clarify this assumption. We found an overall improvement of the BFMDRS movement score of 42% after DBS. This finding is comparable with those of previous studies that found 33% 89% improvements. 20,28,30 The BFMDRS movement scores in patients with torticollis improved 17%. Torticollis patients are reported to respond well to DBS when the STN is stimulated. 3,16,24,26 However, in most of these studies, the patients were rated with TWSTRS. For torticollis symptoms, this scale is more selective than the BFMDRS. When our study was designed, we expected to mainly include patients with generalized, multifocal, or segmental dystonia, and we therefore chose to use the BFMDRS as the rating scale. However, we decided to perform supplementary evaluation with TWSTRS when the study was ongoing to complement the BFMDRS results. The resulting TWSTRS ratings based on video recordings support the conclusion that STN stimulation is at least as effective as GPi stimulation also in the subgroup of patients with torticollis. The improvement in TWSTRS scores in our study was 5% when patients were stimulated at the GPi compared with 51% when the same patients were stimulated at the STN. However, only 4 patients completed the 6 months of GPi stimulation, and there was no significant difference (p = 0.08). A different range (2% 70%) of improvements in TWSTRS scores has been reported for treating torticollis with DBS. 24,26 In our study, the limited TWSTRS score improvement with GPi stimulation could have various explanations. The range of amplitude tested when adjusting the settings might have been too low; maximum amplitude was 4.0 V. The optimal setting can be as high as 4.6 V for some patients when stimulating the GPi for dystonia, 29 but high settings were not tested in our study. Suboptimal location of electrodes could also influence the results. When treating primary dystonia with DBS, the best effects are reported when electrodes are located posteroventrally in the GPi. 29 Although postoperative MR and CT images seem to confirm a good position of the GPi electrodes in torticollis patients, determining the exact location of electrodes by MRI can be difficult because of artifacts from the electrodes. Consequently, suboptimal position of electrodes cannot be excluded. In 3 patients with generalized and multifocal dystonia, the electrodes in the GPi were located more anteriorly than intended. Consistent with this positioning, for 2 of these 3 patients, GPi stimulation had little or negative effect. Only 2 patients in our study had secondary dystonia resulting from earlier treatment (tardive dystonia). The effect of DBS is thought to depend on etiology, and patients with primary dystonia as well as tardive dystonia are reported by most studies to respond well to DBS. 3,28 However, these results are based on stimulation of the GPi, and specific types of dystonia probably respond differently to stimulation of the STN and the GPi. In our study, STN stimulation produced the same or a better effect than GPi stimulation in the 2 patients with tardive dystonia (both with torticollis). However, no conclusions regarding effects on different kinds of dystonia can be drawn from this study because of the small number of patients and the heterogeneity of etiology and phenotype. Further studies with selected groups of dystonia patients are needed to address this question. With respect to the BFMDRS ratings, the effect of DBS was observed in the first week but did not improve between the first week and 6 months of stimulation. A delayed effect of DBS in patients with dystonia has been described. Additional improvement from DBS of the GPi has been reported for up to 1 year postoperatively for patients with generalized dystonia and up to 2 years postoperatively for patients with torticollis. 38 However, the main improvement seems to be during the first 6 months. 8,37 In our study, we therefore considered 6 months of observation to be sufficient. The study design required that stimulation of the new target during the second period be initiated immediately after stimulation of the first target. It has been reported 1543

8 L. Schjerling et al. that pausing DBS in dystonic patients results in a very fast return to preoperative symptoms. 12 However, it cannot be ruled out that stimulation in the first period may change the effect of stimulation in the second period by modulating the pathological pathways involved in dystonia. The BFMDRS movement score was improved by 10.8 points after 6 months of stimulation in the first period and by 13.8 points after an additional 6 months of stimulation in the second period. However, the variation in improvement can be partly accounted for by different occurrence of dropouts. In the first period, all patients completed the DBS regardless of worsened symptoms. In the second period, 3 patients dropped out before the 6-month ratings were performed, possibly affecting the mean 6-month improvement in a positive way. In the intention-to-treat analysis correlation for time was included. In this study, we encountered only a few severe surgical complications of DBS (that is, 2 instances of infection). Others have found increased rates of mortality (< 0.4%), intracranial hemorrhage (< 2%), and infections (< 5%). 19,25,33 Adverse effects such as hyperkinesia were typically resolved with optimal resetting of the stimulation parameters. For 3 patients, hyperkinesia persisted despite adjustment: 2 with STN stimulation and 1 with GPi stimulation. For patients with PD, stimulation of the GPi or STN is used for fluctuations and hyperkinesia. Although GPi stimulation is known to have a direct effect on dyskinesia, STN stimulation is thought to be effective in these patients because of an effect on parkinsonian symptoms causing substantial reductions in medication, thereby avoiding hyperkinesia. 32 For 3 patients, signs of depression developed during GPi stimulation but not during STN stimulation. In patients wth dystonia, depression has been reported with stimulation of the STN as well as the GPi. 15,24 Depression in patients with PD is reported more often when the STN rather than the GPi is the DBS target. 2,10 However, this finding might be a consequence of the abrupt and significant reduction of dopaminergic medication in patients when the STN, in contrast to the GPi, is stimulated and may not be related to the stimulation of the different targets. 11 The effect of DBS on the STN might therefore differ in patients not receiving levodopa. Because all patients in our study had pure dystonia, none received levodopa. Our quality of life analysis of dystonia patients did not suggest a negative effect on mental health scores with STN stimulation. Several studies have reported that quality of life is significantly reduced for patients with both focal and generalized dystonia. 15 The most common scale used to measure quality of life is the SF ; this scale has been validated in comparison with other determinants of quality of life. 27 The SF-36 displays physical and mental scores of the dystonic patient, including vitality, social functioning, and mental health. It has been discussed whether the mental scores are just manifestations of a chronic disabling disease or whether there might be a more direct effect on emotional symptoms. 27 DBS of the GPi improves quality of life in patients with dystonia. Improvement has been shown in physical and mental scores and in physical scores only. 15,16,20,30,31 Few researchers have investigated quality of life for patients with dystonia undergoing STN stimulation. 18,23,24 The largest study, to our knowledge, included 9 patients with torticollis who were treated with STN stimulation and showed improvement of physical health but not of mental health. 24 In our study, stimulation of the STN or the GPi improved physical health, but mental health was not significantly improved. We detected no difference between stimulation of the STN and the GPi. Subthalamic nucleus stimulation needed lower pulse widths than did GPi stimulation. Lower pulse width results in longer battery life. 14 Battery changes carry an inherent risk for infection, which often results in repetitive hospital stays and reoperations for removal of the battery or even the electrodes. Prolonging battery life therefore reduces costs and improves the life of the dystonic patient. Conclusions We have not been able to conclude which is the optimal target of stimulation: the GPi or the STN. This inconclusiveness is because of the heterogeneity of patients, the relatively small number of patients, and the rather high percentage of patients with protocol interruptions. However, in this study, the STN was a safe and promising DBS target, which warrants further evaluation. Simultaneous stimulation of the STN and the GPi also seems safe and might add to the effect of STN stimulation alone. Disclosure Dr. Løkkegaard reports receiving fees for lecturing from Lundbech Pharma, UCB, and Medtronic within the last 3 years. Dr. Karlsborg reports a nonfinancial relationship with Medtronic, which supplies the equipment used in the author s DBS clinic. Author contributions to the study and manuscript preparation include the following. Conception and design: Hjermind, Madsen, Brennum, Løkkegaard, Karlsborg. Acquisition of data: Hjermind, Jensen, Karlsborg. Analysis and interpretation of data: Schjerling. Drafting the article: Schjerling. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Schjerling. Statistical analysis: Schjerling. Analyzing CT/MR images for localization of electrodes: Jespersen. Illustrations: Jespersen. Preoperative information and surgery: Jespersen, Madsen. Drafting the trial protocol: Brennum. References 1. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: , Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP: Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 62: , Andrews C, Aviles-Olmos I, Hariz M, Foltynie T: Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry 81: , Baizabal-Carvallo JF, Roze E, Aya-Kombo M, Romito L, Navarro S, Flamand-Rouvière C, et al: Combined pallidal and subthalamic nucleus deep brain stimulation in secondary dystonia-parkinsonism. Parkinsonism Relat Disord 19: , 2013 (Letter) 5. Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Stan- 1544

9 Subthalamic or pallidal DBS for dystonia daert DG: The pathophysiological basis of dystonias. Nat Rev Neurosci 9: , Chou KL, Hurtig HI, Jaggi JL, Baltuch GH: Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor. Mov Disord 20: , Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE: Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 12: , Coubes P, Cif L, El Fertit H, Hemm S, Vayssiere N, Serrat S, et al: Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg 101: , Fahn S, Bressman SB, Marsden CD: Classification of dystonia. Adv Neurol 78:1 10, Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al: Pallidal versus subthalamic deep-brain stimulation for Parkinson s disease. N Engl J Med 362: , Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J, et al: Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson s disease. Mov Disord 18: , Grabli D, Ewenczyk C, Coelho-Braga MC, Lagrange C, Fraix V, Cornu P, et al: Interruption of deep brain stimulation of the globus pallidus in primary generalized dystonia. Mov Disord 24: , Hammond C, Ammari R, Bioulac B, Garcia L: Latest view on the mechanism of action of deep brain stimulation. Mov Disord 23: , Isaias IU, Alterman RL, Tagliati M: Deep brain stimulation for primary generalized dystonia: long-term outcomes. Arch Neurol 66: , Jahanshahi M, Czernecki V, Zurowski AM: Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia. Mov Disord 26 (Suppl 1):S63 S78, Kiss ZH, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O: The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 130: , Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al: Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21 Sup pl 14:S290 S304, Kleiner-Fisman G, Liang GS, Moberg PJ, Ruocco AC, Hurtig HI, Baltuch GH, et al: Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg 107: 29 36, Krause M, Fogel W, Kloss M, Rasche D, Volkmann J, Tronnier V: Pallidal stimulation for dystonia. Neurosurgery 55: , Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider GH, Poewe W, et al: Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 355: , Lyons KE, Pahwa R: Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. J Neurosurg 104: , Nambu A, Tokuno H, Takada M: Functional significance of the cortico-subthalamo-pallidal hyperdirect pathway. Neurosci Res 43: , Novak KE, Nenonene EK, Bernstein LP, Vergenz S, Cozzens JW, Rezak M: Successful bilateral subthalamic nucleus stimulation for segmental dystonia after unilateral pallidotomy. Stereotact Funct Neurosurg 86:80 86, Ostrem JL, Racine CA, Glass GA, Grace JK, Volz MM, Heath SL, et al: Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 76: , Paluzzi A, Belli A, Bain P, Liu X, Aziz TM: Operative and hardware complications of deep brain stimulation for movement disorders. Br J Neurosurg 20: , Skogseid IM, Ramm-Pettersen J, Volkmann J, Kerty E, Dietrichs E, Røste GK: Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study. Eur J Neurol 19: , Soeder A, Kluger BM, Okun MS, Garvan CW, Soeder T, Jacobson CE, et al: Mood and energy determinants of quality of life in dystonia. J Neurol 256: , Sun B, Chen S, Zhan S, Le W, Krahl SE: Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 97: , Tisch S, Zrinzo L, Limousin P, Bhatia KP, Quinn N, Ashkan K, et al: Effect of electrode contact location on clinical efficacy of pallidal deep brain stimulation in primary generalised dystonia. J Neurol Neurosurg Psychiatry 78: , Valldeoriola F, Regidor I, Mínguez-Castellanos A, Lezcano E, García-Ruiz P, Rojo A, et al: Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry 81:65 69, Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, et al: Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 352: , Vitek JL: Deep brain stimulation for Parkinson s disease. A critical re-evaluation of the STN versus the GPi DBS. Stereotact Funct Neurosurg 78: , Voges J, Hilker R, Bötzel K, Kiening KL, Kloss M, Kupsch A, et al: Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord 22: , Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: , Wichmann T, DeLong MR, Guridi J, Obeso JA: Milestones in research on the pathophysiology of Parkinson s disease. Mov D i s ord 26: , Wöhrle JC, Blahak C, Capelle HH, Fogel W, Bäzner H, Krauss JK: Combined pallidal and subthalamic nucleus stimulation in sporadic dystonia-parkinsonism. Case report. J Neurosurg 116:95 98, Woehrle JC, Blahak C, Kekelia K, Capelle HH, Baezner H, Grips E, et al: Chronic deep brain stimulation for segmental dystonia. Stereotact Funct Neurosurg 87: , Yianni J, Bain PG, Gregory RP, Nandi D, Joint C, Scott RB, et al: Post-operative progress of dystonia patients following globus pallidus internus deep brain stimulation. Eur J Neurol 10: , 2003 Manuscript submitted April 27, Accepted August 27, Please include this information when citing this paper: published online October 11, 2013; DOI: / JNS Part of this work was presented in poster form at the Congress of the European Society for Stereotactic and Functional Neurosurgery, September 22 25, 2010, in Athens, Greece. Supplemental online information: Video: akamai.com/21492/wm.digitalsource-na-regional/jns13-844_ video_1.asx (Media Player). akamai.com/21492/qt.digitalsource-global/jns13-844_video_1. mov (Quicktime). Address correspondence to: Lisbeth Schjerling, M.D., Department of Emergency, Hilleroed University Hospital, Dyrehavej 29, 3400 Hilleroed, Denmark. lisbeth.schjerling@regionh.dk. 1545

Deep Brain Stimulation: Patient selection

Deep Brain Stimulation: Patient selection Deep Brain Stimulation: Patient selection Halim Fadil, MD Movement Disorders Neurologist Kane Hall Barry Neurology Bedford/Keller, TX 1991: Thalamic (Vim) DBS for tremor Benabid AL, et al. Lancet. 1991;337(8738):403-406.

More information

Deep brain stimulation of globus pallidus internus for DYT1 positive primary generalized dystonia

Deep brain stimulation of globus pallidus internus for DYT1 positive primary generalized dystonia Original Article Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences Deep brain stimulation of globus pallidus internus for DYT1 positive primary generalized dystonia

More information

Deep Brain Stimulation for Parkinson s Disease & Essential Tremor

Deep Brain Stimulation for Parkinson s Disease & Essential Tremor Deep Brain Stimulation for Parkinson s Disease & Essential Tremor Albert Fenoy, MD Assistant Professor University of Texas at Houston, Health Science Center Current US Approvals Essential Tremor and Parkinsonian

More information

PACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD

PACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD PACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD WHAT IS DEEP BRAIN STIMULATION? WHY SHOULD YOU CONSIDER DBS SURGERY FOR YOUR PATIENTS? HOW DOES DBS WORK? DBS electrical stimulation overrides abnormal

More information

Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration

Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration doi:10.1093/brain/awn120 Brain (2008), 131,1895^1902 Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration Ioannis U. Isaias, 1 Ron L. Alterman 2 and

More information

Critical Review: What effects do neurosurgical treatments for generalized dystonia have on speech?

Critical Review: What effects do neurosurgical treatments for generalized dystonia have on speech? Critical Review: What effects do neurosurgical treatments for generalized dystonia have on speech? Jana Zalmanowitz M.Cl.Sc (SLP) Candidate University of Western Ontario: School of Communication Sciences

More information

Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life

Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life J Neurosurg 107:29 36, 2007 Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life GALIT KLEINER-FISMAN, M.D., 1 GRACE

More information

Pallidal Deep Brain Stimulation

Pallidal Deep Brain Stimulation Pallidal Deep Brain Stimulation Treatment for Dystonia Dystonia Dystonia is a neurological disorder characterized by involuntary muscle contractions resulting in abnormal postures. These movements may

More information

Punit Agrawal, DO Clinical Assistant Professor of Neurology Division of Movement Disorders OSU Department of Neurology

Punit Agrawal, DO Clinical Assistant Professor of Neurology Division of Movement Disorders OSU Department of Neurology Deep Brain Stimulation for Movement Disorders Punit Agrawal, DO Clinical Assistant Professor of Neurology Division of Movement Disorders OSU Department of Neurology History of DBS 1 History of DBS 1987

More information

Surgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better

Surgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better Surgical Treatment of Movement Stephen Grill, MD, PHD Johns Hopkins University and Parkinson s and Movement Center of Maryland Surgical Treatment of Movement Historical Aspects Preoperative Issues Surgical

More information

Parkinson's Disease Center and Movement Disorders Clinic

Parkinson's Disease Center and Movement Disorders Clinic Parkinson's Disease Center and Movement Disorders Clinic 7200 Cambridge Street, 9th Floor, Suite 9A Houston, Texas 77030 713-798-2273 phone www.jankovic.org Dystonia Diagnosis Dystonia is a neurologic

More information

ORIGINAL CONTRIBUTION. Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement

ORIGINAL CONTRIBUTION. Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement ORIGINAL CONTRIBUTION Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement Effects of Reimplantation Mathieu Anheim, MD; Alina Batir, MD; Valérie Fraix, MD;

More information

Surgical Treatment for Movement Disorders

Surgical Treatment for Movement Disorders Surgical Treatment for Movement Disorders Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence St Vincent

More information

Deep brain stimulation for dystonia

Deep brain stimulation for dystonia Hu and Stead Translational Neurodegeneration 2014, 3:2 Translational Neurodegeneration REVIEW Deep brain stimulation for dystonia Wei Hu * and Matt Stead * Open Access Abstract Deep brain stimulation (DBS)

More information

P rimary generalised dystonia (PGD) is a movement disorder

P rimary generalised dystonia (PGD) is a movement disorder 1314 PAPER Effect of electrode contact location on clinical efficacy of pallidal deep brain stimulation in primary generalised dystonia S Tisch, L Zrinzo, P Limousin, K P Bhatia, N Quinn, K Ashkan, M Hariz...

More information

Review Article Dystonia and the Role of Deep Brain Stimulation

Review Article Dystonia and the Role of Deep Brain Stimulation International Scholarly Research Network ISRN Surgery Volume 2011, Article ID 193718, 5 pages doi:10.5402/2011/193718 Review Article Dystonia and the Role of Deep Brain Stimulation Thomas L. Ellis Wake

More information

Deep Brain Stimulation: Indications and Ethical Applications

Deep Brain Stimulation: Indications and Ethical Applications Deep Brain Stimulation Overview Kara D. Beasley, DO, MBe, FACOS Boulder Neurosurgical and Spine Associates (303) 562-1372 Deep Brain Stimulation: Indications and Ethical Applications Instrument of Change

More information

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about

More information

doi: /brain/awt009 Brain 2013: 136; Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years

doi: /brain/awt009 Brain 2013: 136; Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years doi:10.1093/brain/awt009 Brain 2013: 136; 761 769 761 BRAIN A JOURNAL OF NEUROLOGY Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years Richard A. Walsh, 1,2

More information

Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson s disease

Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson s disease CLINICAL ARTICLE Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson s disease Leonardo A. Frizon, MD, 1,2 Sean J. Nagel, MD, 1 Francis J. May, MS, 1 Jianning Shao,

More information

Treatment of Dystonia with Deep Brain Stimulation

Treatment of Dystonia with Deep Brain Stimulation Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics Treatment of Dystonia with Deep Brain Stimulation Jill L. Ostrem* and Philip A. Starr *Department of Neurology,

More information

SUPPLEMENTAL DIGITAL CONTENT

SUPPLEMENTAL DIGITAL CONTENT SUPPLEMENTAL DIGITAL CONTENT FIGURE 1. Unilateral subthalamic nucleus (STN) deep brain stimulation (DBS) electrode and internal pulse generator. Copyright 2010 Oregon Health & Science University. Used

More information

The Canadian multicentre study of deep brain stimulation for cervical dystonia

The Canadian multicentre study of deep brain stimulation for cervical dystonia doi:10.1093/brain/awm229 The Canadian multicentre study of deep brain stimulation for cervical dystonia Brain (2007), 130, 2879^2886 Zelma H. T. Kiss, 1 Kristina Doig-Beyaert, 1 Michael Eliasziw, 1,2 Joseph

More information

Surgical Treatment: Patient Edition

Surgical Treatment: Patient Edition Parkinson s Disease Clinic and Research Center University of California, San Francisco 505 Parnassus Ave., Rm. 795-M, Box 0114 San Francisco, CA 94143-0114 (415) 476-9276 http://pdcenter.neurology.ucsf.edu

More information

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives. Deep Brain Stimulation in the Treatment of Movement Disorders Disclosures None Eleanor K Orehek, M.D. Movement Disorders Specialist Noran Neurological Clinic 1 2 Objectives To provide an overview of deep

More information

Deep Brain Stimulation: Surgical Process

Deep Brain Stimulation: Surgical Process Deep Brain Stimulation: Surgical Process Kia Shahlaie, MD, PhD Assistant Professor Bronte Endowed Chair in Epilepsy Research Director of Functional Neurosurgery Minimally Invasive Neurosurgery Department

More information

Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study

Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study Marie Vidailhet, Laurent Vercueil, Jean-Luc Houeto, Pierre Krystkowiak, Christelle Lagrange,

More information

DBS efficacia, complicanze in cronico e nuovi orizzonti terapeutici

DBS efficacia, complicanze in cronico e nuovi orizzonti terapeutici DBS efficacia, complicanze in cronico e nuovi orizzonti terapeutici TECNICHE DI NEUROMODULAZIONE Invasiva: odeep Brain Stimulation Non Invasiva: o Transcranial Magnetic Stimulation (TMS) o Transcranial

More information

See Policy CPT/HCPCS CODE section below for any prior authorization requirements

See Policy CPT/HCPCS CODE section below for any prior authorization requirements Effective Date: 1/1/2019 Section: SUR Policy No: 395 1/1/19 Medical Policy Committee Approved Date: 8/17; 2/18; 12/18 Medical Officer Date APPLIES TO: Medicare Only See Policy CPT/HCPCS CODE section below

More information

The Canadian multicentre study of deep brain stimulation for cervical dystonia

The Canadian multicentre study of deep brain stimulation for cervical dystonia Brain Advance Access published September 28, 2007 doi:10.1093/brain/awm229 Brain (2007) Page 1 of 8 The Canadian multicentre study of deep brain stimulation for cervical dystonia Zelma H. T. Kiss, 1 Kristina

More information

Surgical Management of Parkinson s Disease

Surgical Management of Parkinson s Disease Surgical Management of Parkinson s Disease Shyamal H. Mehta MD, PhD Assistant Professor of Neurology, Movement Disorders Division Mayo Clinic College of Medicine Mayo Clinic, Arizona 2016 MFMER slide-1

More information

ORIGINAL CONTRIBUTION. Subthalamic Stimulation in Parkinson Disease

ORIGINAL CONTRIBUTION. Subthalamic Stimulation in Parkinson Disease Subthalamic Stimulation in Parkinson Disease A Multidisciplinary Approach ORIGINAL CONTRIBUTION J. L. Houeto, MD; P. Damier, MD, PhD; P. B. Bejjani, MD; C. Staedler, MD; A. M. Bonnet, MD; I. Arnulf, MD;

More information

ORIGINAL CONTRIBUTION. Acute Deep-Brain Stimulation of the Internal and External Globus Pallidus in Primary Dystonia

ORIGINAL CONTRIBUTION. Acute Deep-Brain Stimulation of the Internal and External Globus Pallidus in Primary Dystonia ORIGINAL CONTRIBUTION Acute Deep-Brain Stimulation of the Internal and External Globus Pallidus in Primary Dystonia Functional Mapping of the Pallidum Jean-Luc Houeto, MD, PhD; Jérôme Yelnik, MD, PhD;

More information

Deep brain stimulation for camptocormia in dystonia and Parkinson s disease

Deep brain stimulation for camptocormia in dystonia and Parkinson s disease J Neurol (2011) 258:96 103 DOI 10.1007/s00415-010-5695-0 ORIGINAL COMMUNICATION Deep brain stimulation for camptocormia in dystonia and Parkinson s disease Hans-Holger Capelle Christoph Schrader Christian

More information

DEEP BRAIN STIMULATION

DEEP BRAIN STIMULATION DEEP BRAIN STIMULATION Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson s Disease

Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson s Disease Movement Disorders Vol. 25, No. 5, 2010, pp. 578 586 Ó 2010 Movement Disorder Society Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson s Disease Elena Moro,

More information

Citation for published version (APA): Contarino, M. F. (2013). Improving surgical treatment for movement disorders

Citation for published version (APA): Contarino, M. F. (2013). Improving surgical treatment for movement disorders UvA-DARE (Digital Academic Repository) Improving surgical treatment for movement disorders Contarino, M.F. Link to publication Citation for published version (APA): Contarino, M. F. (2013). Improving surgical

More information

Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years

Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years ORIGINAL ARTICLE Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years L. M. Romito a,b, *, G. Zorzi a, *, C. E. Marras c, A. Franzini a, N. Nardocci a and A. Albanese a,b a

More information

Evidence compendium. Research study summaries supporting the use of Medtronic deep brain stimulation (DBS) for Parkinson s disease

Evidence compendium. Research study summaries supporting the use of Medtronic deep brain stimulation (DBS) for Parkinson s disease Evidence compendium Research study summaries supporting the use of Medtronic deep brain stimulation (DBS) for Parkinson s disease CONTENTS Introduction... 4 Index of study summaries... 6 Parkinson s disease

More information

Deep Brain Stimulation. Is It Right for You?

Deep Brain Stimulation. Is It Right for You? Deep Brain Stimulation Is It Right for You? Northwestern Medicine Deep Brain Stimulation What is DBS? Northwestern Medicine Central DuPage Hospital is a regional destination for the treatment of movement

More information

Palladotomy and Pallidal Deep Brain Stimulation

Palladotomy and Pallidal Deep Brain Stimulation Palladotomy and Pallidal Deep Brain Stimulation Parkinson s disease Parkinson s Disease is a common neurodegenerative disorder that affects about 1:100 individuals over the age of 60. In a small percentage

More information

DEEP BRAIN STIMULATION (DBS) is a standard treatment

DEEP BRAIN STIMULATION (DBS) is a standard treatment 1320 ORIGINAL ARTICLE Fast-Track Programming and Rehabilitation Model: A Novel Approach to Postoperative Deep Brain Stimulation Patient Care David B. Cohen, MD, Michael Y. Oh, MD, Susan M. Baser, MD, Cindy

More information

DBS Programming. Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18

DBS Programming. Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18 DBS Programming Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18 Disclosure The University of Maryland has received research funding form InSightec and the Focused Ultrasound

More information

Deep brain stimulation in the treatment of dyskinesia and dystonia

Deep brain stimulation in the treatment of dyskinesia and dystonia Neurosurg Focus 17 (1):E2, 2004, Click here to return to Table of Contents Deep brain stimulation in the treatment of dyskinesia and dystonia HIROKI TODA, M.D., PH.D., CLEMENT HAMANI, M.D., PH.D., AND

More information

Deep Brain Stimulation and Movement Disorders

Deep Brain Stimulation and Movement Disorders Deep Brain Stimulation and Movement Disorders Farrokh Farrokhi, MD Neurosurgery Maria Marsans, PA-C Neurosurgery Virginia Mason June 27, 2017 OBJECTIVES Understand the role of Deep Brain Stimulation (DBS)

More information

Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes

Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes 1 Lysholm Department of Neuroradiology, National Hospital for Neurology & Neurosurgery, London, UK 2 Unit of Functional Neurosurgery, Sobell Department of Motor Neuroscience, UCL Institute of Neurology,

More information

Deep Brain Stimulation Surgery for Parkinson s Disease

Deep Brain Stimulation Surgery for Parkinson s Disease Deep Brain Stimulation Surgery for Parkinson s Disease Demystifying Medicine 24 January 2012 Kareem A. Zaghloul, MD, PhD Staff Physician, Surgical Neurology Branch NINDS Surgery for Parkinson s Disease

More information

Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder

Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder BRAIN STIMULATION LABORATORY Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder OCD Awareness Day NOLAN WILLIAMS, M.D. Instructor Department of Psychiatry Stanford University October

More information

Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients

Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients J Neurosurg 98:779 784, 2003 Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients ATSUSHI UMEMURA, M.D., JURG L. JAGGI, PH.D., HOWARD I. HURTIG, M.D., ANDREW D. SIDEROWF,

More information

Parkinson disease: Parkinson Disease

Parkinson disease: Parkinson Disease Surgical Surgical treatment treatment for for Parkinson disease: Parkinson Disease the Present and the Future the Present and the Future Olga Klepitskaya, MD Associate Professor of Neurology Co-Director,

More information

A lthough levodopa treatment remains the gold standard

A lthough levodopa treatment remains the gold standard 1640 PAPER Stimulation of the subthalamic nucleus in Parkinson s disease: a 5 year follow up W M M Schüpbach, N Chastan, M L Welter, J L Houeto, V Mesnage, A M Bonnet, V Czernecki, D Maltête, A Hartmann,

More information

Short term surgical complications after subthalamic deep brain stimulation for Parkinson s disease: does old age matter?

Short term surgical complications after subthalamic deep brain stimulation for Parkinson s disease: does old age matter? Levi et al. BMC Geriatrics (2015) 15:116 DOI 10.1186/s12877-015-0112-2 RESEARCH ARTICLE Open Access Short term surgical complications after subthalamic deep brain stimulation for Parkinson s disease: does

More information

Deep brain stimulation (DBS) has been shown to be

Deep brain stimulation (DBS) has been shown to be clinical article J Neurosurg 124:908 916, 2016 Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson s disease Jill L. Ostrem, MD, 1 Nathan Ziman,

More information

Deep brain stimulation in movement disorders: stereotactic coregistration of two-dimensional electrical field modeling and magnetic resonance imaging

Deep brain stimulation in movement disorders: stereotactic coregistration of two-dimensional electrical field modeling and magnetic resonance imaging J Neurosurg 103:949 955, 2005 Deep brain stimulation in movement disorders: stereotactic coregistration of two-dimensional electrical field modeling and magnetic resonance imaging SIMONE HEMM, PH.D, GÉRARD

More information

C. Moreau, MD L. Defebvre, MD, PhD A. Destée, MD, PhD S. Bleuse, PhD F. Clement, MD J.L. Blatt, MD, PhD P. Krystkowiak, MD, PhD D.

C. Moreau, MD L. Defebvre, MD, PhD A. Destée, MD, PhD S. Bleuse, PhD F. Clement, MD J.L. Blatt, MD, PhD P. Krystkowiak, MD, PhD D. ARTICLES STN-DBS frequency effects on freezing of gait in advanced Parkinson disease C. Moreau, MD L. Defebvre, MD, PhD A. Destée, MD, PhD S. Bleuse, PhD F. Clement, MD J.L. Blatt, MD, PhD P. Krystkowiak,

More information

symptoms of Parkinson s disease EXCEPT.

symptoms of Parkinson s disease EXCEPT. M. Angele Theard, M.D Asst. Professor, Washington University, St. Louis, MO Quiz team; Shobana Rajan, M.D; Suneeta Gollapudy, MD; Verghese Cherian, M.D, M. Angele Theard, MD This quiz is being published

More information

Basal ganglia motor circuit

Basal ganglia motor circuit Parkinson s Disease Basal ganglia motor circuit 1 Direct pathway (gas pedal) 2 Indirect pathway (brake) To release or augment the tonic inhibition of GPi on thalamus Direct pathway There is a tonic inhibition

More information

Deep Brain Stimulation

Deep Brain Stimulation Deep Brain Stimulation Policy Number: 7.01.63 Last Review: 8/2017 Origination: 8/2001 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for deep brain

More information

THE EFFECTS OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION ON VOCAL TRACT DYNAMICS IN PARKINSON S DISEASE

THE EFFECTS OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION ON VOCAL TRACT DYNAMICS IN PARKINSON S DISEASE 11 th Bienniel Speech Motor Control Conference, Colonial Williamsburg, Virginia, 2002. THE EFFECTS OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION ON VOCAL TRACT DYNAMICS IN PARKINSON S DISEASE Steven Barlow,

More information

Troubleshooting algorithms for common DBS related problems in tremor and dystonia

Troubleshooting algorithms for common DBS related problems in tremor and dystonia Troubleshooting algorithms for common DBS related problems in tremor and dystonia Elena Moro, MD, PhD, FEAN, FAAN Movement Disorder Center, CHU Grenoble, Grenoble Alpes University, INSERM U1216, Grenoble,

More information

The motor regulator. 1) Basal ganglia/nucleus

The motor regulator. 1) Basal ganglia/nucleus The motor regulator 1) Basal ganglia/nucleus Neural structures involved in the control of movement Basal Ganglia - Components of the basal ganglia - Function of the basal ganglia - Connection and circuits

More information

Dystonia: Title. A real pain in the neck. in All the Wrong Places

Dystonia: Title. A real pain in the neck. in All the Wrong Places Focus on CME at the University of Western Ontario Dystonia: Title in All the Wrong Places A real pain in the neck By Mandar Jog, MD, FRCPC and; Mary Jenkins, MD, FRCPC What is dystonia? Dystonia is a neurologic

More information

Deep Brain Stimulation

Deep Brain Stimulation Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

High-Field in vivo Visualization of the Human Globus Pallidus Using 7T MRI

High-Field in vivo Visualization of the Human Globus Pallidus Using 7T MRI Niederer 1 High-Field in vivo Visualization of the Human Globus Pallidus Using 7T MRI Abstract In the past several decades the introduction of high-resolution, three-dimensional modeling techniques have

More information

Rapid assessment of gait and speech after subthalamic deep brain stimulation

Rapid assessment of gait and speech after subthalamic deep brain stimulation SNI: Stereotactic, a supplement to Surgical Neurology International OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor Antonio A. F. DeSalles, MD University of California,

More information

EMERGING TREATMENTS FOR PARKINSON S DISEASE

EMERGING TREATMENTS FOR PARKINSON S DISEASE EMERGING TREATMENTS FOR PARKINSON S DISEASE Katerina Markopoulou, MD, PhD Director Neurodegenerative Diseases Program Department of Neurology NorthShore University HealthSystem Clinical Assistant Professor

More information

Linköping University Post Print. Patient-specific models and simulations of deep brain stimulation for postoperative follow-up

Linköping University Post Print. Patient-specific models and simulations of deep brain stimulation for postoperative follow-up inköping University Post Print Patient-specific models and simulations of deep brain stimulation for postoperative follow-up Mattias Åström, Elina Tripoliti, Irene Martinez-Torres, udvic U. Zrinzo, Patricia

More information

Name of Policy: Deep Brain Stimulation

Name of Policy: Deep Brain Stimulation Name of Policy: Deep Brain Stimulation Policy #: 347 Latest Review Date: June 2013 Category: Surgery Policy Grade: B Background/Definitions: As a general rule, benefits are payable under Blue Cross and

More information

F unctional stereotactic surgery is now well established for

F unctional stereotactic surgery is now well established for PAPER Effect of chronic pallidal deep brain on off period dystonia and sensory symptoms in advanced Parkinson s disease T J Loher, J-M Burgunder, S Weber, R Sommerhalder, J K Krauss... See end of article

More information

Deep brain stimulation in neurologic disorders

Deep brain stimulation in neurologic disorders ARTICLE IN PRESS Parkinsonism and Related Disorders 13 (2007) 1 16 Review Deep brain stimulation in neurologic disorders Casey Halpern a,b, Howard Hurtig a,b,, Jurg Jaggi a,b, Murray Grossman a,b, Michelle

More information

Patient selection for surgery: Hyperkinetic movement disorders

Patient selection for surgery: Hyperkinetic movement disorders Patient selection for surgery: Hyperkinetic movement disorders Alfons Schnitzler, MD, PhD Dept. of Neurology, Movement Disorder and Neuromodulation, Heinrich-Heine-University Düsseldorf, Germany Hyperkinetic

More information

Deep brain stimulation for dystonia

Deep brain stimulation for dystonia 1 AP-HP, Department of Neurology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France 2 Centre de Recherche de l Institut du Cerveau et de la Moelle épinière (CRICM), CNRS UMR 7225, UPMC Université Paris

More information

No Financial Disclosures

No Financial Disclosures Deep Brain Stimulation: A Physician and Patient Perspective Jessica McClure Warren Marks, MD Cook Children s Medical Center Cook Children s Health Foundation Endowed Chair in Neurosciences Department of

More information

Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia

Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia original article Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia Marie Vidailhet, M.D., Ph.D., Laurent Vercueil, M.D., Jean-Luc Houeto, M.D., Ph.D., Pierre Krystkowiak,

More information

The phenomenology and treatment of idiopathic adult-onset truncal dystonia: a retrospective review

The phenomenology and treatment of idiopathic adult-onset truncal dystonia: a retrospective review Ehrlich and Frucht Journal of Clinical Movement Disorders (2016) 3:15 DOI 10.1186/s40734-016-0044-9 RESEARCH ARTICLE Open Access The phenomenology and treatment of idiopathic adult-onset truncal dystonia:

More information

I n 1991 Benabid et al introduced deep brain stimulation

I n 1991 Benabid et al introduced deep brain stimulation PAPER Multicentre European study of thalamic stimulation in essential tremor: a six year follow up O Sydow, S Thobois, F Alesch, J D Speelman, study collaborators... See Editorial Commentary, pp1361 2

More information

Ablative procedures for the treatment of Parkinson s disease

Ablative procedures for the treatment of Parkinson s disease Ablative procedures for the treatment of Parkinson s disease Zeiad Y. Fayed MD Neurosurgery department Ain Shams University 1 2 Pallidotomy Pallidotomy Indications: Non tremor dominant PD Levodopa induced

More information

Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.

Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland,

More information

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association.

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association. Deep Brain Stimulation Page 1 of 31 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association. Title: Deep Brain Stimulation Professional Institutional Original Effective Date:

More information

S ince the pioneering work of Benabid et and Pollak

S ince the pioneering work of Benabid et and Pollak 409 PAPER Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement N A Hamid, R D Mitchell, P

More information

The oscillatory activity in the Parkinsonian subthalamic nucleus investigated using the macro-electrodes for deep brain stimulation

The oscillatory activity in the Parkinsonian subthalamic nucleus investigated using the macro-electrodes for deep brain stimulation Clinical Neurophysiology 113 (2002) 1 6 www.elsevier.com/locate/clinph The oscillatory activity in the Parkinsonian subthalamic nucleus investigated using the macro-electrodes for deep brain stimulation

More information

COGNITIVE SCIENCE 107A. Motor Systems: Basal Ganglia. Jaime A. Pineda, Ph.D.

COGNITIVE SCIENCE 107A. Motor Systems: Basal Ganglia. Jaime A. Pineda, Ph.D. COGNITIVE SCIENCE 107A Motor Systems: Basal Ganglia Jaime A. Pineda, Ph.D. Two major descending s Pyramidal vs. extrapyramidal Motor cortex Pyramidal system Pathway for voluntary movement Most fibers originate

More information

Clinical Policy Title: Deep brain stimulation

Clinical Policy Title: Deep brain stimulation Clinical Policy Title: Deep brain stimulation Clinical Policy Number: 09.03.02 Effective Date: July 1, 2015 Initial Review Date: February 18, 2015 Most Recent Review Date: March 15, 2017 Next Review Date:

More information

Deep brain s,mula,on refers to implan,ng electrodes into specific areas of the brain and hooking the electrodes up to pacemaker- like devices in

Deep brain s,mula,on refers to implan,ng electrodes into specific areas of the brain and hooking the electrodes up to pacemaker- like devices in 1 Deep brain s,mula,on refers to implan,ng electrodes into specific areas of the brain and hooking the electrodes up to pacemaker- like devices in order to send signals into the brain to jam the abnormal

More information

Topic: Deep Brain Stimulation Date of Origin: April Section: Surgery Approved Date: April Policy No: 84 Effective Date: July 1, 2014

Topic: Deep Brain Stimulation Date of Origin: April Section: Surgery Approved Date: April Policy No: 84 Effective Date: July 1, 2014 Medical Policy Manual Topic: Deep Brain Stimulation Date of Origin: April 1998 Section: Surgery Approved Date: April 2014 Policy No: 84 Effective Date: July 1, 2014 IMPORTANT REMINDER Medical Policies

More information

As clinical experience with deep-brain stimulation (DBS) of

As clinical experience with deep-brain stimulation (DBS) of ORIGINAL RESEARCH K.V. Slavin K.R. Thulborn C. Wess H. Nersesyan Direct Visualization of the Human Subthalamic Nucleus with 3T MR Imaging BACKGROUND AND PURPOSE: Electrical stimulation of the subthalamic

More information

Dr Barry Snow. Neurologist Auckland District Health Board

Dr Barry Snow. Neurologist Auckland District Health Board Dr Barry Snow Neurologist Auckland District Health Board Dystonia and Parkinson s disease Barry Snow Gowers 1888: Tetanoid chorea Dystonia a movement disorder characterized by sustained or intermittent

More information

ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease

ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease Parkinson s Disease Cardinal Signs: Resting tremor Rigidity Bradykinesia Postural instability Other Symptoms Dystonia Dysphagia Autonomic

More information

MRI-guided STN DBS in Parkinson s disease without microelectrode recording: efficacy and safety

MRI-guided STN DBS in Parkinson s disease without microelectrode recording: efficacy and safety MRI-guided STN DBS in Parkinson s disease without microelectrode recording: efficacy and safety T Foltynie, L Zrinzo,,2 I Martinez-Torres, 3 E Tripoliti, E Petersen, 4 E Holl,,5 I Aviles-Olmos, M Jahanshahi,

More information

Deep brain stimulation: What can patients expect from it?

Deep brain stimulation: What can patients expect from it? MEDICAL GRAND ROUNDS ANDRE MACHADO, MD, PhD* Director, Center for Neurological Restoration, Neurological Institute, Cleveland Clinic HUBERT H. FERNANDEZ, MD Section Head, Movement Disorders, Center for

More information

Deep brain stimulation (DBS) is now well established

Deep brain stimulation (DBS) is now well established Pallidal Stimulation in Parkinson s Disease Does Not Induce Apathy Clément Lozachmeur, M.D. Sophie Drapier, M.D. Gabriel Robert, M.D., Ph.D. Thibaut Dondaine Bruno Laviolle, M.D., Ph.D. Paul Sauleau, M.D.

More information

Lecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I!

Lecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I! Lecture XIII. Brain Diseases I - Parkinsonism! Bio 3411! Wednesday!! Lecture XIII. Brain Diseases - I.! 1! Brain Diseases I! NEUROSCIENCE 5 th ed! Page!!Figure!!Feature! 408 18.9 A!!Substantia Nigra in

More information

Beta and Tremor-Related Oscillations in the Motor Thalamus of Essential Tremor Patients

Beta and Tremor-Related Oscillations in the Motor Thalamus of Essential Tremor Patients IETF - WD Hutchison Feb 214 requesting $25, Beta and Tremor-Related Oscillations in the Motor Thalamus of Essential Tremor Patients 1. Specific aims of proposal The proposed study will examine beta oscillations

More information

ORIGINAL CONTRIBUTION

ORIGINAL CONTRIBUTION ORIGINAL CONTRIBUTION Common Misdiagnosis of a Common Neurological Disorder How Are We Misdiagnosing Essential Tremor? Samay Jain, MD; Steven E. Lo, MD; Elan D. Louis, MD, MS Background: As a common neurological

More information

Deep Brain Stimulation for Treatment of Parkinson s Disease Deep brain stimulation, Parkinson s disease, subthalamic nucleus, stereotactic surgery

Deep Brain Stimulation for Treatment of Parkinson s Disease Deep brain stimulation, Parkinson s disease, subthalamic nucleus, stereotactic surgery ISPUB.COM The Internet Journal of Neuromonitoring Volume 7 Number 1 Deep Brain Stimulation for Treatment of Parkinson s Disease Deep brain stimulation, Parkinson s disease, subthalamic nucleus, stereotactic

More information

Gangli della Base: un network multifunzionale

Gangli della Base: un network multifunzionale Gangli della Base: un network multifunzionale Prof. Giovanni Abbruzzese Centro per la Malattia di Parkinson e i Disordini del Movimento DiNOGMI, Università di Genova IRCCS AOU San Martino IST Basal Ganglia

More information

Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up

Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up 1 CHU Clermont-Ferrand, Department of Neurology, Gabriel Montpied Hospital, Clermont-Ferrand, France; 2 Univ Clermont 1, UFR Medecine, Clermont-Ferrand, France; 3 INRA, Centre Clermont-Ferrand Theix, Unite

More information

Deep Brain Stimulation. Description. Section: Surgery Effective Date: April 15, 2015

Deep Brain Stimulation. Description. Section: Surgery Effective Date: April 15, 2015 Subject: Deep Brain Stimulation Page: 1 of 22 Last Review Status/Date: March 2015 Deep Brain Stimulation Description Deep brain stimulation (DBS) involves the stereotactic placement of an electrode into

More information

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better.

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better. Dystonia What are movement disorders? Movement disorders are conditions that cause involuntary body movements. With all movement disorders, abnormal signals from the brain cause patients to have trouble

More information